13 research outputs found
Shape Theory Applied to Molecular Docking and Automatic Localization of Ligand Binding Pockets in Large Proteins
Automatic search of cavities and binding mode analysis
between
a ligand and a 3D protein receptor are challenging problems in drug
design or repositioning. We propose a solution based on a shape theory
theorem for an invariant coupled system of ligand–protein.
The theorem provides a matrix representation with the exact formulas
to be implemented in an algorithm. The method involves the following
results: (1) exact formulae for the shape coordinates of a located-rotated
invariant coupled system; (2) a parameterized search based on a suitable
domain of van der Waals radii; (3) a scoring function for the discrimination
of sites by measuring the distance between two invariant coupled systems
including the atomic mass; (4) a matrix representation of the Lennard-Jones
potential type 6–12 and 6–10 as the punctuation function
of the algorithm for a molecular docking; and (5) the optimal molecular
docking as a solution of an optimization problem based on the exploration
of an exhaustive set of rotations. We apply the method in the xanthine
oxidase protein with the following ligands: hypoxanthine, febuxostat,
and chlorogenic acid. The results show automatic cavity detection
and molecular docking not assisted by experts with meaningful amino
acid interactions. The method finds better affinities than the expert
software for known published cavities
An Engineered Lantibiotic Synthetase That Does Not Require a Leader Peptide on Its Substrate
Ribosomally synthesized and post-translationally modified
peptides
are a rapidly expanding class of natural products. They are typically
biosynthesized by modification of a C-terminal segment of the precursor
peptide (the core peptide). The precursor peptide also contains an
N-terminal leader peptide that is required to guide the biosynthetic
enzymes. For bioengineering purposes, the leader peptide is beneficial
because it allows promiscuous activity of the biosynthetic enzymes
with respect to modification of the core peptide sequence. However,
the leader peptide also presents drawbacks as it needs to be present
on the core peptide and then removed in a later step. We show that
fusing the leader peptide for the lantibiotic lacticin 481 to its
biosynthetic enzyme LctM allows the protein to act on core peptides
without a leader peptide. We illustrate the use of this methodology
for preparation of improved lacticin 481 analogues containing non-proteinogenic
amino acids
Synthesis of Cyclic and Cage Borosilicates Based on Boronic Acids and Acetoxysilylalkoxides. Experimental and Computational Studies of the Stability Difference of Six- and Eight-Membered Rings
A series
of borosilicates was synthesized, where the structure of the borosilicate
core was easily modulated using two strategies: blocking of condensation
sites and controlling the stoichiometry of the reaction. Thus, on
the one hand, the condensation of phenylboronic or 3-hydroxyphenylboronic
acid with diacetoxysilylalkoxide [(<sup><i>t</i></sup>BuO)(Ph<sub>3</sub>CO)Si(OAc)<sub>2</sub>] led to the formation of borosilicates
(<sup><i>t</i></sup>BuO)(Ph<sub>3</sub>CO)Si{(μ-O)BPh}<sub>2</sub>(μ-O) (<b>1</b>), [{(<sup><i>t</i></sup>BuO)(Ph<sub>3</sub>CO)Si(μ-O)BPh(μ-O)}<sub>2</sub>] (<b>2</b>), and [{(<sup><i>t</i></sup>BuO)(Ph<sub>3</sub>CO)Si(μ-O)B(3-HOPh)(μ-O)}<sub>2</sub>] (<b>3</b>) with a cyclic inorganic B<sub>2</sub>SiO<sub>3</sub> or B<sub>2</sub>Si<sub>2</sub>O<sub>4</sub> core, respectively. On the other hand,
the reaction of phenylboronic acid with triacetoxysilylalkoxide (Ph<sub>3</sub>CO)Si(OAc)<sub>3</sub> in 3:2 ratio resulted in the formation
of a cagelike structure [{(Ph<sub>3</sub>CO)Si(μ-O)<sub>2</sub>BPh(μ-O)}<sub>2</sub>] (<b>4</b>) with B<sub>4</sub>Si<sub>4</sub>O<sub>10</sub> core, while the reaction of the boronic acid
with silicon tetraacetate generated an unusual 1,3-bis(acetate)-1,3-diphenyldiboraxane
PhB(μ-O)(μ-O,O′-OAc)<sub>2</sub>BPh (<b>5</b>). Additionally, compound <b>1</b> was used to evaluate the
possibility to form N→B donor–acceptor bond between
the boron atom in the borosilicates and a nitrogen donor. Thus, coordination
of <b>1</b> with piperazine yielded a tricyclic [{(<sup><i>t</i></sup>BuO)(Ph<sub>3</sub>CO)Si(OBPh)<sub>2</sub>(μ-O)}<sub>2</sub>·C<sub>4</sub>H<sub>10</sub>N<sub>2</sub>] compound <b>6</b> with two borosilicate rings bridged by a piperazine molecule.
Finally, the processes involved in the formation of the six- and eight-membered
rings (B<sub>2</sub>SiO<sub>3</sub> and B<sub>2</sub>Si<sub>2</sub>O<sub>4</sub>) in compounds <b>1</b> and <b>2</b> were
explored using solution <sup>1</sup>H NMR studies and density functional
theory calculations. These molecules represent to the best of our
knowledge first examples of cyclic molecular borosilicates containing
SiO<sub>4</sub> units
Efficacy of a Binuclear Cyclopalladated Compound Therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis and its inhibitory effect on Topoisomerase 1B
Leishmaniasis is a disease found throughout the (sub)tropical parts of the world caused by protozoan parasites of the Leishmania genus. Despite the numerous problems associated with existing treatments, pharmaceutical companies continue to neglect the development of better ones. The high toxicity of current drugs combined with emerging resistance makes the discovery of new therapeutic alternatives urgent. Here we report the evaluation of a binuclear cyclopalladated complex containing Pd(II) and N,N' -dimethylbenzylamine (Hdmba) against Leishmania amazonensis. The compound [Pd(dmba)(μ-N3)]2 (CP2) inhibits promastigote growth (IC50 = 13.2 ± 0.7 μM) and decreases the proliferation of intracellular amastigotes in in vitro incubated macrophages (IC50 = 10.2 ± 2.2 μM) without a cytotoxic effect when tested against peritoneal macrophages (CC50 = 506.0 ± 10.7 μM). Additionally, CP2 was also active against T. cruzi intracellular amastigotes (IC50 = 2.3 ± 0.5 μM, Selective Index = 225), an indication of its potential for use in Chagas disease therapy. In vivo assays using L. amazonensis-infected BALB/c showed an 80% reduction in parasite load when compared to infected and non-treated animals. Also, compared to amphotericin B treatment, CP2 did not show any side effects, which was corroborated by the analysis of plasma levels of different hepatic and renal biomarkers. Furthermore, CP2 was able to inhibit Leishmania donovani topoisomerase 1B (Ldtopo1B), a potentially important target in this parasite
Structural Modularity of Unique Multicomponent Hydrogen-Bonded Organic Frameworks Based on Organosilanetriols and Silanediols as Molecular Building Blocks
In
this study we examined the use of a new class of molecular building
blocks with tetrahedral nodes based on organo-bis(silanetriols) (1,4-[(HO)<sub>3</sub>SiOCEt<sub>2</sub>]<sub>2</sub>C<sub>6</sub>H<sub>4</sub> (<b>1</b>) and 4,4′-[(HO)<sub>3</sub>SiOCEt<sub>2</sub>]<sub>2</sub>-(1,1′-biphenyl) (<b>2</b>)) and
organo-bis(silanediol) (1,4-[{(HO)<sub>2</sub>(<sup><i>t</i></sup>BuO)Si}OCEt<sub>2</sub>]<sub>2</sub>C<sub>6</sub>H<sub>4</sub> (<b>3</b>)) for the synthesis of multicomponent
hydrogen-bonded organic frameworks (HOFs) with adjustable supramolecular
patterns, and modular assembly. Thus, such reticular arrangements
were readily obtained by the cocrystallization of bridged organosilanols
(<b>1</b>, <b>2</b>, and <b>3</b>) with an organic
diamine (1,4-diazabicyclo[2.2.2]octane (<b>a</b>) or <i>trans</i>-1,2-bis(4-pyridyl)ethylene (<b>b</b>)) to yield
the corresponding HOFs <b>1a</b>, <b>1b</b>, <b>2a</b>, <b>2b</b>, <b>3a</b>, and <b>3b</b>. Single-crystal
X-ray diffraction analysis revealed that the dimensionality of the
network, and by consequence, its porosity, can be easily engineered
by means of the modulation of the central organic backbone of the
organosilanol-based tectons, as well as by the Lewis basicity and
the size of the corresponding organic diamine. In this context, it
was found that although <b>1a</b> presents a nonporous arrangement,
changing either the organic diamine as in <b>1b</b>, or the
spacer’s size as in <b>2a</b>, it is possible to generate
one-dimensional channels or zero-dimensional voids, respectively.
Moreover, through gas sorption experiments, it was demonstrated that <b>1b</b> exhibits structural flexibility and permanent porosity
with selective adsorption of CO<sub>2</sub> over N<sub>2</sub>
Causal analysis of plasma IL-8 on carotid intima media thickness, a measure of subclinical atherosclerosis
No abstract available
Mechanism of Pyrogallol Red Oxidation Induced by Free Radicals and Reactive Oxidant Species. A Kinetic and Spectroelectrochemistry Study
Pyrogallol red (PGR) presents high
reactivity toward reactive (radical
and nonradical) species (RS). This property of PGR, together with
its characteristic spectroscopic absorption in the visible region,
has allowed developing methodologies aimed at evaluating the antioxidant
capacity of foods, beverages, and human fluids. These methods are
based on the evaluation of the consumption of PGR induced by RS and
its inhibition by antioxidants. However, at present, there are no
reports regarding the degradation mechanism of PGR, limiting the extrapolation
to how antioxidants behave in different systems comprising different
RS. In the present study, we evaluate the kinetics of PGR consumption
promoted by different RS (peroxyl radicals, peroxynitrite, nitrogen
dioxide, and hypochlorite) using spectroscopic techniques and detection
of product by HPLC mass spectrometry. The same pattern of oxidation
and spectroscopic properties of the products is observed, independently
of the RS employed. Mass analysis indicates the formation of only
one product identified as a quinone derivative, excluding the formation
of peroxides or hydroperoxides and/or chlorinated compounds, in agreement
with FOX’s assays and oxygen consumption experiments. Cyclic
voltammetry, carried out at different pH’s, shows an irreversible
oxidation of PGR, indicating the initial formation of a phenoxy radical
and a second charge transfer reaction generating an ortho-quinone
derivative. Spectroelectrochemical oxidation of PGR shows oxidation
products with identical UV–visible absorption properties to
those observed in RS-induced oxidation
Hydrotrope-Induced Inversion of Salt Effects on the Cloud Point of an Extended Surfactant
The authors report on the effects of electrolytes spanning a range of (NaOc, NaSCN, NaNO3, NaBr, NaCl, NaBu, NaOAc, Na2SO4, Na2HPO4, and Na2CO3) and (LiCl, NaCl, KCl, CsCl, and choline chloride) on the aq. soly. of an extended surfactant. The surfactant is anionic with a long hydrophobic tail as well as a significant fraction of propylene oxide groups and ethylene oxide groups (C12-14-PO16-EO2-SO4Na, X-AES). In the absence of electrolytes, X-AES exhibits a cloud-point temp. that decreases with increasing surfactant concn. After the addn. of salts to the surfactant solns., various shifts in the soly. curves are obsd. These shifts follow precisely the same Hofmeister series that is found for salting-in and salting-out effects in protein solns. In the presence of different concns. of sodium xylene sulfonate (SXS), the soly. of the surfactant increases. In this context, SXS can be considered to be a salting-in salt. However, when the electrolytes are added to an aq. soln. of X-AES and SXS the Hofmeister series reverses for divalent anions such as Na2SO4, Na2HPO4, and Na2CO3. Studies on the phase behavior and micelle structures using polarization microscopy, freeze-etch TEM, and NMR measurements indicate a dramatic change in the coexisting phases on the addn. of SXS